May 24, 2024 · Form 4 insider transaction
Kewalramani Reshma bought 1,565 shares of Vertex Pharmaceuticals Incorporated at $187.53 per share, a transaction worth $293.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.